Consolidated Statements of Shareholders' Equity - USD ($) $ in Millions | Total | Common Stock | Additional Paid-In Capital | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Loss |
Common stock outstanding, beginning balance (in shares) at Dec. 31, 2022 | | 225,200,000 | | | | |
Balance at beginning of period at Dec. 31, 2022 | $ 3,961 | $ 2 | $ 3,036 | $ 1,010 | $ (14) | $ (73) |
Treasury stock, common, beginning balance (in shares) at Dec. 31, 2022 | | | | | 400,000 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Share-based compensation expense | 14 | | 14 | | | |
Proceeds from employee stock purchase plan (in shares) | | 200,000 | | | | |
Proceeds from employee share purchase plan | 5 | | 5 | | | |
Vested restricted stock units, net (in shares) | | 600,000 | | | | |
Exercise of stock options (in shares) | | 300,000 | | | | |
Exercise of stock options | 7 | | 7 | | | |
Tax withholding payments for net share-settled equity awards | (11) | | (11) | | | |
Series A convertible preferred stock conversion to common stock (in shares) | | 7,600,000 | | | | |
Series A convertible preferred stock conversion to common stock | 161 | | 161 | | | |
Series A convertible preferred stock dividends | (7) | | | (7) | | |
Changes in retirement benefit obligations, net of income tax | 1 | | | | | 1 |
Common stock repurchased (in shares) | | | | | 900,000 | |
Common stock repurchased | (34) | | | | $ (34) | |
Net income | 82 | | | 82 | | |
Common stock outstanding, ending balance (in shares) at Apr. 01, 2023 | | 233,900,000 | | | | |
Balance at end of period at Apr. 01, 2023 | 4,179 | $ 2 | 3,212 | 1,085 | $ (48) | (72) |
Treasury stock, common, ending balance (in shares) at Apr. 01, 2023 | | | | | 1,300,000 | |
Common stock outstanding, beginning balance (in shares) at Dec. 31, 2022 | | 225,200,000 | | | | |
Balance at beginning of period at Dec. 31, 2022 | 3,961 | $ 2 | 3,036 | 1,010 | $ (14) | (73) |
Treasury stock, common, beginning balance (in shares) at Dec. 31, 2022 | | | | | 400,000 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Changes in retirement benefit obligations, net of income tax | 1 | | | | | |
Net income | 359 | | | | | |
Common stock outstanding, ending balance (in shares) at Sep. 30, 2023 | | 252,500,000 | | | | |
Balance at end of period at Sep. 30, 2023 | 4,692 | $ 3 | 3,642 | 1,362 | $ (245) | (70) |
Treasury stock, common, ending balance (in shares) at Sep. 30, 2023 | | | | | 6,200,000 | |
Common stock outstanding, beginning balance (in shares) at Apr. 01, 2023 | | 233,900,000 | | | | |
Balance at beginning of period at Apr. 01, 2023 | 4,179 | $ 2 | 3,212 | 1,085 | $ (48) | (72) |
Treasury stock, common, beginning balance (in shares) at Apr. 01, 2023 | | | | | 1,300,000 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Share-based compensation expense | 14 | | 14 | | | |
Proceeds from employee stock purchase plan (in shares) | | 200,000 | | | | |
Proceeds from employee share purchase plan | 8 | | 8 | | | |
Vested restricted stock units, net (in shares) | | 100,000 | | | | |
Exercise of stock options (in shares) | | 700,000 | | | | |
Exercise of stock options | 15 | | 15 | | | |
Series A convertible preferred stock conversion to common stock (in shares) | | 17,400,000 | | | | |
Series A convertible preferred stock conversion to common stock | 373 | $ 1 | 372 | | | |
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax | 1 | | | | | 1 |
Common stock repurchased (in shares) | | | | | 4,200,000 | |
Common stock repurchased | (166) | | | | $ (166) | |
Share Repurchase Program, Excise Tax | (2) | | | | (2) | |
Net income | 182 | | | 182 | | |
Common stock outstanding, ending balance (in shares) at Jul. 01, 2023 | | 252,300,000 | | | | |
Balance at end of period at Jul. 01, 2023 | 4,604 | $ 3 | 3,621 | 1,267 | $ (216) | (71) |
Treasury stock, common, ending balance (in shares) at Jul. 01, 2023 | | | | | 5,500,000 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Share-based compensation expense | 15 | | 15 | | | |
Proceeds from employee stock purchase plan (in shares) | | 200,000 | | | | |
Proceeds from employee share purchase plan | 6 | | 6 | | | |
Changes in retirement benefit obligations, net of income tax | 1 | | | | | 1 |
Common stock repurchased (in shares) | | | | | 700,000 | |
Common stock repurchased | (29) | | | | $ (29) | |
Net income | 95 | | | 95 | | |
Common stock outstanding, ending balance (in shares) at Sep. 30, 2023 | | 252,500,000 | | | | |
Balance at end of period at Sep. 30, 2023 | $ 4,692 | $ 3 | 3,642 | 1,362 | $ (245) | (70) |
Treasury stock, common, ending balance (in shares) at Sep. 30, 2023 | | | | | 6,200,000 | |
Common stock outstanding, beginning balance (in shares) at Dec. 30, 2023 | 245,100,000 | 252,900,000 | | | | |
Balance at beginning of period at Dec. 30, 2023 | $ 4,749 | $ 3 | 3,663 | 1,509 | $ (311) | (115) |
Treasury stock, common, beginning balance (in shares) at Dec. 30, 2023 | 7,800,000 | | | | 7,800,000 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Share-based compensation expense | $ 15 | | 15 | | | |
Proceeds from employee stock purchase plan (in shares) | | 100,000 | | | | |
Proceeds from employee share purchase plan | 5 | | 5 | | | |
Vested restricted stock units, net (in shares) | | 700,000 | | | | |
Exercise of stock options (in shares) | | 200,000 | | | | |
Exercise of stock options | 5 | | 5 | | | |
Tax withholding payments for net share-settled equity awards | (20) | | (20) | | | |
Changes in retirement benefit obligations, net of income tax | 2 | | | | | 2 |
Common stock repurchased (in shares) | | | | | 300,000 | |
Common stock repurchased | (13) | | | | $ (13) | |
Net income | 82 | | | 82 | | |
Common stock outstanding, ending balance (in shares) at Mar. 30, 2024 | | 253,900,000 | | | | |
Balance at end of period at Mar. 30, 2024 | $ 4,825 | $ 3 | 3,668 | 1,591 | $ (324) | (113) |
Treasury stock, common, ending balance (in shares) at Mar. 30, 2024 | | | | | 8,100,000 | |
Common stock outstanding, beginning balance (in shares) at Dec. 30, 2023 | 245,100,000 | 252,900,000 | | | | |
Balance at beginning of period at Dec. 30, 2023 | $ 4,749 | $ 3 | 3,663 | 1,509 | $ (311) | (115) |
Treasury stock, common, beginning balance (in shares) at Dec. 30, 2023 | 7,800,000 | | | | 7,800,000 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Changes in retirement benefit obligations, net of income tax | $ 4 | | | | | |
Common stock repurchased | (634) | | | | | |
Share Repurchase Program, Excise Tax | (7) | | | | | |
Net income | $ 428 | | | | | |
Common stock outstanding, ending balance (in shares) at Sep. 28, 2024 | 235,400,000 | 254,600,000 | | | | |
Balance at end of period at Sep. 28, 2024 | $ 4,606 | $ 3 | 3,722 | 1,937 | $ (945) | (111) |
Treasury stock, common, ending balance (in shares) at Sep. 28, 2024 | 19,200,000 | | | | 19,200,000 | |
Common stock outstanding, beginning balance (in shares) at Mar. 30, 2024 | | 253,900,000 | | | | |
Balance at beginning of period at Mar. 30, 2024 | $ 4,825 | $ 3 | 3,668 | 1,591 | $ (324) | (113) |
Treasury stock, common, beginning balance (in shares) at Mar. 30, 2024 | | | | | 8,100,000 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Share-based compensation expense | 15 | | 15 | | | |
Proceeds from employee stock purchase plan (in shares) | | 200,000 | | | | |
Proceeds from employee share purchase plan | 9 | | 9 | | | |
Vested restricted stock units, net (in shares) | | 100,000 | | | | |
Exercise of stock options (in shares) | | 100,000 | | | | |
Exercise of stock options | 4 | | 4 | | | |
Changes in retirement benefit obligations, net of income tax | 1 | | | | | 1 |
Common stock repurchased (in shares) | | | | | 700,000 | |
Common stock repurchased | (41) | | | | $ (41) | |
Net income | 198 | | | 198 | | |
Common stock outstanding, ending balance (in shares) at Jun. 29, 2024 | | 254,300,000 | | | | |
Balance at end of period at Jun. 29, 2024 | 5,011 | $ 3 | 3,696 | 1,789 | $ (365) | (112) |
Treasury stock, common, ending balance (in shares) at Jun. 29, 2024 | | | | | 8,800,000 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Share-based compensation expense | 16 | | 16 | | | |
Proceeds from employee stock purchase plan (in shares) | | 100,000 | | | | |
Proceeds from employee share purchase plan | 5 | | 5 | | | |
Exercise of stock options (in shares) | | 200,000 | | | | |
Exercise of stock options | 5 | | 5 | | | |
Changes in retirement benefit obligations, net of income tax | 1 | | | | | 1 |
Common stock repurchased (in shares) | | | | | 10,400,000 | |
Common stock repurchased | (580) | | | | $ (580) | |
Share Repurchase Program, Excise Tax | (6) | | | | | |
Net income | $ 148 | | | 148 | | |
Common stock outstanding, ending balance (in shares) at Sep. 28, 2024 | 235,400,000 | 254,600,000 | | | | |
Balance at end of period at Sep. 28, 2024 | $ 4,606 | $ 3 | $ 3,722 | $ 1,937 | $ (945) | $ (111) |
Treasury stock, common, ending balance (in shares) at Sep. 28, 2024 | 19,200,000 | | | | 19,200,000 | |